金属诱导的基因毒性事件:在零星和家族ALS之间可能有区别
William Wu Kim1,2, Gregory Zarus1, Breanna Alman1
1Office of Innovation and Analytics (OIA), Agency for Toxic Substances and Disease Registry(ATSDR), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), 4770 Buford Highway, Mailstop S106-5, Chamblee, GA 30341, USA.
Toxics
|June 25, 2025
概括
接触金属与肌缩性侧面硬化症 (ALS) 有关. 本次审查强调了导致DNA损伤的金属,可能会恶化ALS,并确定了生物标志物和治疗方法的关键数据缺口.
科学领域:
- 环境毒理学环境毒理学
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
背景情况:
- 肌缩性侧面硬化症 (ALS) 涉及运动神经元损失,越来越多的证据将DNA损伤与家族 (fALS) 和零星 (sALS) 形式联系起来.
- 暴露于金属是一种可疑的危险因素,在毒理学概况中观察到基因毒性和神经退行.
研究的目的:
- 审查ALS病变的金属诱导基因毒性及其在疾病风险中的作用.
- 总结ALS中DNA损伤生物标志物,并讨论与金属相关的基因毒性机制.
- 探索fALS和sALS之间的基因毒性生物标志物的潜在区别.
主要方法:
- 对毒性物质和疾病注册局 (ATSDR) 毒理学概况的全面审查.
- 对金属暴露,基因毒性和ALS现有文献的分析.
- 鉴定了15种具有与ALS相关的基因毒性指标的金属.
主要成果:
- 十五种金属 (例如,,,,) 显示与ALS病变相关的基因毒性.
- 暴露于金属可以加剧fALS中的遗传突变,并导致sALS中的运动神经元退化.
- 有证据将重金属暴露与两种ALS形式的基因毒性终点联系在一起,但对于几个标记物存在数据差距.
结论:
- 暴露于金属与ALS有关,基因毒性影响起着重要作用.
- 识别尚未探索的基因毒性终点和理解机制对于生物标志物开发和治疗策略至关重要.
- 对纵向暴露,机制和生物标志物的进一步研究对于ALS的预防和治疗是有必要的.
相关概念视频
Spontaneous and Induced Mutations
166
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
166
Mutations
40.4K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
40.4K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K


